osteoarthritis

Job cuts employee layoffs firings or downsizing Scissors dividing individuals positioned on colorful blocks
Biotech

Enlivex lays off 60% of staff, 'substantially' cuts exec pay

Enlivex will lay off 60% of staff, end preclinical R&D and trim execs’ salaries as the biotech keeps cash flowing to its osteoarthritis drug.
James Waldron Oct 19, 2026 9:41am
fired layoffs cut executives dismissed

Kolon TissueGene shrinks workforce after pivotal trial miss

Aug 18, 2026 4:00pm
Knee arthritis osteoarthritis

Kolon’s cell-based gene therapy fails ph.3 osteoarthritis test

Jul 20, 2026 9:25am
obesity overweight weight loss weigh

Lilly's obesity triple threat tops phase 3 efficacy forecasts

Dec 11, 2025 8:15am
Red stop sign on road

Eli Lilly sidelines pain prospect in another pipeline shift

Oct 30, 2025 2:19pm
Broom sweep clean

Novartis axes osteoarthritis asset and radioligand therapy

Apr 29, 2025 5:24am